An Observational Study of Patients With Chronic Kidney Disease

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05774392

Enrollment

Registered

2023-03-17

Start date

2025-04-30

Completion date

2025-04-07

Last updated

2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Kidney Disease, Kidney Disease, Chronic

Brief summary

TARGET-KIDNEY is an observational research study to conduct a comprehensive review of outcomes for patients with chronic kidney disease (CKD) and end-stage renal disease (ESKD).

Interventions

OTHERObservational

Observational

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

Disease Cohort Inclusion Criteria: * Adult\* patients at the time of enrollment with a diagnosis of CKD/ESKD by ICD-10 code in the EHR interface

Exclusion criteria

* Death * Manual removal (sponsor or site request) * No EHR interface encounter \> 3 years Engaged Cohort Inclusion Criteria: * Adult \* patients diagnosed and managed for CKD/ESKD invited to participate * Ability to provide written informed consent

Design outcomes

Primary

Measure	Time frame
To characterize the natural history of disease in patients with CKD/ESKD.	20 Years
To assess safety and effectiveness of CKD/ESKD treatments and treatments for complications of either condition	20 Years

Secondary

Measure	Time frame
To evaluate provider management practices in the treatment of patients with CKD/ESKD	20 Years
To evaluate longitudinal and patient reported outcomes in CKD/ESKD	20 Years
To select and evaluate quality of care measures for patients with CKD/ESKD	20 Years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026